National Heart, Lung, and Blood Institute (NHLBI): Infections trials

The registry lists 12 Infections studies with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 2 2No phase 10(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Cross-sectional Characterization of Idiopathic BronchiectasisCompletedNCT01264055
• Longitudinal Studies of HIV-Associated Lung Infections and Complications (Lung HIV)CompletedNCT00933595Not applicable
• Coated Endotracheal Tube and Mucus Shaver to Prevent Hospital-Acquired InfectionsCompletedNCT00341354Phase 2
• Retrovirus Epidemiology Donor Study-II (REDS-II)CompletedNCT00097006
• Role of Toxins in Lung Infections Caused by Pseudomonas AeruginosaCompletedNCT00027183
• Infection and Cardiovascular DiseaseCompletedNCT00005547
• Inflammation, Infection, and Future Cardiovascular RiskCompletedNCT00005496
• Retrovirus Epidemiology Donor Study I (REDS I)CompletedNCT00005278
• Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2)CompletedNCT00005274
• Pulmonary Complications of HIV Infection Study (PACS)CompletedNCT00005273
• Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women With Chronic InfectionsCompletedNCT00001890Phase 2
• Viral Activation Transfusion Study (VATS)CompletedNCT00000593Not applicable